Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Total Current Liabilities (2016 - 2026)

Oramed Pharmaceuticals filings provide 15 years of Total Current Liabilities readings, the most recent being $19.1 million for Q4 2025.

  • Quarterly Total Current Liabilities rose 235.73% to $19.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.1 million through Dec 2025, up 235.73% year-over-year, with the annual reading at $19.1 million for FY2025, 235.73% up from the prior year.
  • Total Current Liabilities hit $19.1 million in Q4 2025 for Oramed Pharmaceuticals, up from $6.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $78.2 million in Q3 2023 and bottomed at $1.1 million in Q2 2023.
  • Average Total Current Liabilities over 5 years is $13.6 million, with a median of $6.0 million recorded in 2021.
  • The largest annual shift saw Total Current Liabilities soared 1098.08% in 2023 before it tumbled 93.25% in 2024.
  • Oramed Pharmaceuticals' Total Current Liabilities stood at $7.7 million in 2021, then dropped by 24.99% to $5.7 million in 2022, then surged by 826.11% to $53.2 million in 2023, then crashed by 89.32% to $5.7 million in 2024, then soared by 235.73% to $19.1 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Total Current Liabilities are $19.1 million (Q4 2025), $6.1 million (Q3 2025), and $3.7 million (Q2 2025).